Paragraph 1 Procedural provisions relating to the refusal or amendment of, or imposition of conditions relating to, clinical trial authorizations and the suspension or termination of clinical trials
This paragraph applies where, before 30th October 2005—
a sponsor has been given a notice as referred to in regulation 26(1) of the Clinical Trials Regulations; or
a sponsor or investigator has been served with a notice in accordance with regulation 31(1) of the Clinical Trials Regulations.
If—
the period of 28 days; or
such longer period as the licensing authority has allowed in the particular case,
has not expired, the sponsor or investigator may, by 30th November 2005, give notice of his wish to make written or oral representations to the appropriate committee.
If the sponsor or investigator gives this notice, he shall be treated as if he had given notice of his wish to make written or oral representations to the appropriate committee in accordance with regulation 26(1) or regulation 31(7) of the Clinical Trials Regulations.